Dr. Atena Aghaee, Mashhad university of medical sciences, Iran
Dr. Atena Aghaee is an Assistant Professor of Nuclear Medicine at Mashhad University of Medical Sciences (MUMS), Iran. She works at the Nuclear Medicine Research Center and has made significant contributions to the field. Dr. Aghaee also holds the position of Chief Manager at the Iranian Society of Nuclear Medicine in Tehran, Iran, since March 2023. She serves as a member of the Examining Board for the Recruitment Exam (since February 2023) and is the Responsible Professor for the Periodical Evaluation Committee of Nuclear Medicine Assistants at MUMS (since September 2021). Previously, she was the Academic Deputy of the Nuclear Medicine Department at MUMS from December 2020 to December 2022. Additionally, Dr. Aghaee has been leading the Nuclear Medicine Ward at Ghaem Hospital, Mashhad, since July 2019.
Education:
Specialty Board of National Nuclear (MUMS, Sep. 2012 – Sep. 2016): She completed a focused specialty board program, and her thesis examined a randomized clinical trial comparing the efficacy of low versus high doses of radioiodine in treating intermediate-risk differentiated thyroid cancer.
Doctorate of Medicine (MD) (MUMS, Sep. 2005 – Sep. 2012): Dr. Aghaee’s medical thesis evaluated the relationship between urinary cystatin C and lipocalin 2 with glomerular and tubule-interstitial injury in renal pathology in nephrotic syndrome patients.
Master of Medical Education (MUMS, Sep. 2021 – Sep. 2023): In this more recent educational pursuit, Dr. Aghaee deepened her knowledge in medical education.
Post-secondary in Experimental Science (Imam Hussein University, Sep. 2004 – Jun. 2005): This was the foundation for her future academic journey in health sciences.
Diploma of Experimental Science (Imam Hussein High School, Sep. 2001 – Jun. 2004): This diploma marked the start of her educational path in the sciences.
Professional Profiles:
Orcid Profile
Google Scholar
Professional Experience:
Dr. Atena Aghaee is an accomplished professional in the field of Nuclear Medicine, currently holding several key roles at esteemed institutions in Iran. She is the Chief Manager at the Iranian Society of Nuclear Medicine in Tehran, a position she has held since March 2023. Dr. Aghaee is also a Responsible Professor at Mashhad University of Medical Sciences in the Department of Nuclear Medicine, where she has been actively involved since September 2021. Furthermore, she served as the Academic Deputy for the Nuclear Medicine Department at Mashhad University of Medical Sciences from December 2020 to December 2022.Her leadership extends to the Ghaem Hospital in Mashhad, where she has been the Head of the Nuclear Medicine Ward since July 2019, under the supervision of Mashhad University of Medical Sciences. In addition, Dr. Aghaee is an Assistant Professor and Member of the Nuclear Medicine Research Center at Mashhad University of Medical Sciences, a position she has held since April 2019. She has been actively involved in the academic and clinical aspects of nuclear medicine, contributing to research and medical education in the field.Earlier in her career, Dr. Aghaee worked as a Nuclear Medicine Physician at the Taleghani Nuclear Medicine Center, Taleghani Hospital in Abadan, Khuzestan, Iran, from October 2016 to June 2017. Prior to this, she completed her Resident of Nuclear Medicine program at Ghaem Hospital from September 2012 to September 2016, under the supervision of Mashhad University of Medical Sciences.Dr. Aghaee’s academic journey began with her Medical Internship at Mashhad University of Medical Sciences from September 2005 to September 2012, where she laid the foundation for her expertise in medicine and nuclear medicine.
Research Interests:
Nuclear Medicine Imaging Techniques: Research on improving diagnostic imaging methods such as PET, SPECT, and other advanced imaging modalities in the context of nuclear medicine.
Radioactive Isotopes in Cancer Therapy: Investigating the use of radiopharmaceuticals for the targeted treatment of cancers, including dosimetry and therapy planning.
Clinical Applications of Nuclear Medicine: Exploring new clinical applications for nuclear medicine in diagnosing and treating a wide variety of diseases, including neurological, cardiac, and oncological conditions.
Radiobiology and Radiation Safety: Research on the biological effects of ionizing radiation in patients and healthcare workers, along with developing new radiation safety protocols.
Advancements in Molecular Imaging: Studying molecular imaging techniques that could aid in early detection of diseases at a cellular or molecular level.
Radiopharmaceutical Development: Research on new radiopharmaceuticals, focusing on both diagnostic and therapeutic applications.
Patient Care and Outcomes in Nuclear Medicine: Investigating how nuclear medicine can improve patient outcomes, including studies on treatment effectiveness, side effects, and patient quality of life.
Award and Honors:
Tomio Inoue Award (16th Asia Oceania Congress of Nuclear Medicine and Biology, Bali, Indonesia, Sep. 2024)
Professor Ralph Blumhardt Award (ACNM Annual Meeting and SNMMI Mid-Winter Meeting at the American College of Nuclear Medicine, Orlando, Florida, USA, Feb. 2024)
Top-Ranked Researcher of the Faculty of Medicine (21st Festival of Research and Technology Week, Mashhad University of Medical Sciences, Mashhad, Iran, Dec. 2023)
Best ACNM Nuclear Medicine Research Abstract (ACNM Annual Meeting and SNMMI Mid-Winter Meeting, Virtual, Feb. 2022)
Best ACNM Nuclear Medicine Research Abstract (ACNM Annual Meeting and SNMMI Mid-Winter Meeting, Virtual, Jan. 2021)
Best Lecture Award (19th National Congress of Nuclear Medicine, Hamadan, Iran, May 2014)
Top Notable Publications:
Redifferentiation Therapies in Thyroid Oncology: Molecular and Clinical Aspects
Journal of Clinical Medicine
Published on 2024-11-21
DOI: 10.3390/jcm13237021
Contributors: Petra Petranović Ovčariček, Murat Tuncel, Atena Aghaee, Alfredo Campennì, Luca Giovanella
Theranostics of Thyroid Cancer
Seminars in Nuclear Medicine
Published on 2024-07
DOI: 10.1053/j.semnuclmed.2024.01.011
Contributors: Luca Giovanella, Murat Tuncel, Atena Aghaee, Alfredo Campenni, Armando De Virgilio, Petra Petranović Ovčariček
Evaluation of Arterial Stiffness and Its Relation to Innovative Anthropometric Indices in Persian Adults
International Journal of Hypertension
Published on 2023-01-23
DOI: 10.1155/2023/2180923
Contributors: Zahra Ataee, Atena Aghaee, Seyyed Reza Sobhani, Elaheh Ebrahimi Miandehi, Parisa Pirzadeh, Maryam Alinezhad-Namaghi, Saeid Eslami, Sahar Sobhani, Giacomo Pucci
Is There a Relationship Between Vascularity and Echogenicity of Thyroid Lobes in Ultrasonography with BMI? A Large Retrospective Cohort Study
Journal of Diagnostic Medical Sonography
Published on 2022-09
DOI: 10.1177/87564793221095780
Contributors: Sahar Sobhani, Forough Kalantari, Seyed Rasoul Zakavi, Susan Shafiei, Elahe Ebrahimi Miandehi, Saeed Eslami, Atena Aghaee
Peptide Receptor Radionuclide Therapy (PRRT) in Radioiodine-Refractory Thyroid Cancer: A Case Report of Significant Response to Lu177 DOTA-TATE Treatment
Archives of Endocrinology and Metabolism
Published on 2022-03-23
DOI: 10.20945/2359-3997000000451
Contributors: Saeideh Ataei-Nakhaei, Kamran Aryana, Sayyed Mostafa Mostafavi, Hadis Mohammadzadeh Kosari, Mohammad Esmatinia, Atena Aghaee
Conclusion:
Dr. Atena Aghaee is a highly deserving candidate for the Best Researcher Award. Her exceptional contributions to thyroid oncology and nuclear medicine, her recognition through prestigious awards, and her consistent involvement in high-impact publications reflect her dedication to advancing medical research. While there are areas for improvement, such as fostering broader collaborations and expanding her research to include patient-centered outcomes, her track record and continued impact on the field demonstrate her suitability for this prestigious award. Dr. Aghaee’s work not only advances scientific knowledge but also directly contributes to improving patient care in thyroid cancer and other related fields.